EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications

María Carretero-Fernández, Antonio José Cabrera-Serrano, Lucía Ruíz Durán, Mariam Ibañez, Marco Bonilla, Francisco Mesa, Juan Francisco Gutiérrez-Bautista, Rachid Chahboun, Fernando Jesús Reyes-Zurita, Joaquín Martínez-Lopez, Rosa Collado, Juan Sainz

Translational Oncology · 2026-07 · 69 · 102796

DOI: 10.1016/j.tranon.2026.102796 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Oncology, 2026-07. Verfasst von María Carretero-Fernández und 11 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Gra…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 292 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regional Government of Andalusia Ministry of Health and Consumer Affairs, Junta de Andalucía, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is best understood as a dynamically evolving genomic ecosystem shaped by inherited susceptibility, early oncogenic events, and continuous selective pressures. We propose an evolutionary genomics framework integrating germline risk, disease initiation, clonal diversification, and therapeutic adaptation into a unified model of MM biology. Polygenic risk burden, rare predisposing variants, and alterations in DNA repair and telomere pathways create a permissive background that influences precursor states and immune interactions. Primary cytogenetic events, particularly immunoglobulin heavy chain (IgH) translocations and hyperdiploidy, establish biologically distinct founding clones and constrain subsequent evolutionary trajectories. Disease progression is driven by secondary chromosomal alterations, copy number changes, MYC activation, TP53 loss, and structural rearrangements, promoting genomic instability and transcriptional plasticity. Longitudinal studies reveal branching clonal architectures shaped by treatment-driven selection. Integrating germline and somatic landscapes within an evolution-aware precision framework may improve risk stratification, anticipate high-risk trajectories, and support adaptive strategies to achieve more durable disease control. While polygenic risk scores (PRS) provide insight into inherited susceptibility, they are not yet clinically actionable for risk stratification or screening in MM and currently remain research tools. This framework provides a clinically oriented basis for applying genomic biomarkers to risk stratification, treatment selection, and longitudinal monitoring.

Schlagwörter

Stichwörter der Autor:innen

Copy number variationsCytogenetic analysisDrug therapy, germline susceptibility, somatic alterations, genetic risk factor…Genetic predisposition to diseaseGenome-wide association studyMultiple myelomaMutation

Autor:innen und Institutionen

  • Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Granada, Spain; Instituto de Investigación Biosanataria IBs.Granada, Gran…
  • Department of hematology, Hospital General de Valencia, Valencia, Spain.
  • Department of Periodontics, School of Dentistry, University of Granada, Granada 18071, Spain.
  • Department of Organic Chemistry, Faculty of Sciences, University of Granada, Granada, Spain.
  • Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.
  • H12O-CNIO Hematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de I…

Förderung

  • Regional Government of Andalusia Ministry of Health and Consumer Affairs
  • Junta de Andalucía
  • Carlos III Health Institute

Zitieren

APA

Carretero-Fernández, M., Cabrera-Serrano, A. J., Durán, L. R., Ibañez, M., Bonilla, M., Mesa, F., Gutiérrez-Bautista, J. F., Chahboun, R., Reyes-Zurita, F. J., Martínez-Lopez, J., Collado, R., & Sainz, J. (2026). Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications. Translational Oncology, 69, 102796. https://doi.org/10.1016/j.tranon.2026.102796

Vancouver

Carretero-Fernández M, Cabrera-Serrano AJ, Durán LR, Ibañez M, Bonilla M, Mesa F, et al. Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications. Translational Oncology. 2026;69:102796. doi:10.1016/j.tranon.2026.102796

BibTeX
@article{CarreteroFernndez2026,
  author = {Carretero-Fernández, María and Cabrera-Serrano, Antonio José and Durán, Lucía Ruíz and Ibañez, Mariam and Bonilla, Marco and Mesa, Francisco and Gutiérrez-Bautista, Juan Francisco and Chahboun, Rachid and Reyes-Zurita, Fernando Jesús and Martínez-Lopez, Joaquín and Collado, Rosa and Sainz, Juan},
  title = {Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications},
  journal = {Translational Oncology},
  year = {2026},
  volume = {69},
  pages = {102796},
  doi = {10.1016/j.tranon.2026.102796}
}
Kostenlos starten →